Preparation of bicyclic 1,2,4-trioxanes from γ,δ-unsaturated ketones

Organic Letters

Volumn 11, Issue 3, 2009, Pages 507-510

  Ramirez, Armando P ^a   Thomas, Andrew M ^a   Woerpel, K A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 TRIOXANE; 1,2,4-TRIOXANE; ALKENE; HETEROCYCLIC COMPOUND; HYDROGEN PEROXIDE; KETONE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; CYCLIZATION; STEREOISOMERISM; SYNTHESIS;

ALKENES; CATALYSIS; CYCLIZATION; HETEROCYCLIC COMPOUNDS; HYDROGEN PEROXIDE; KETONES; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 60849089373     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol8022853     Document Type: Article

References (50)

1. (a) Haynes, R. K.; Vonwiller, S. C. Acc. Chem. Res. 1997, 30, 73-79.
2. (b) Jefford, C. W. Curr. Med. Chem. 2001, 8, 1803-1826.
3. (c) Wu, Y. Ace. Chem. Res. 2002, 35, 255-259.
4. (d) Dembitsky, V. M. Eur. J. Med. Chem. 2008, 43, 223-251.
5. (a) Klayman, D. L. Science 1985, 228, 1049-1055.
6. (b) Hien, T. T.; White, N. J. Lancet 1993, 341, 603-608.
7. (c) Bhattacharya, A. K.; Sharma, R. P. Heterocycles 1999, 51, 1681-1745.
8. (d) Dhingra, V.; Rao, K. V.; Narasu, M. L. Life Sci. 2000, 66, 279-300.
9. (e) Woodrow, C. J.; Haynes, R. K.; Krishna, S. Postgrad. Med. J. 2005, 81, 71-78.
10. (a) Sachs, J.; Malaney, P. Nature 2002, 415, 680-685.
11. (b) Whitty, C. J. M.; Rowland, M.; Sanderson, F.; Mutabingwa, T. K. Brit. Med. J. 2002, 325, 1221-1224.
12. (c) Barnes, K. I.; White, N. J. Acta Trop. 2005, 94, 230-240.
13. (d) Woodrow, C. J.; Krishna, S. Cell. Mol. Life Sci. 2006, 63, 1586-1596.
14. (a) McCullough, K. J.; Nojima, M. Curr. Org. Chem. 2001, 5, 601-636.
15. (b) Jefford, C. W. Curr. Opin. Invest. Drugs 2004, 5, 866-872.
16. (c) Tang, Y.; Dong, Y.; Vennerstrom, J. L. Med. Res. Rev. 2004, 24, 425-448.
17. (a) Efferth, T. Drug Resist. Updates 2005,8, 85-97.
18. (b) Jansen, F. H.; Soomro, S. A. Curr. Med. Chem. 2007, 14, 3243-3259.
19. Jung, M.; Schinazi, R. F. Bioorg. Med. Chem. Lett. 1994, 4, 931- 934.
20. Romero, M. R.; Efferth, T.; Serrano, M. A.; Castaño, B.; Macias, R. I. R.; Briz, O.; Marin, J. J. G. Antiviral Res. 2005, 68, 75-83.
21. (a) Jin, H.-X.; Liu, H.-H.; Zhang, Q.; Wu, Y. J. Org. Chem. 2005, 70, 4240-4247.
22. (b) Zhang, Q.; Jin, H.-X.; Wu, Y. Tetrahedron 2006, 62, 11627-11634.
23. (c) Zhang, Q.; Wu, Y. Tetrahedron 2007, 63, 10189-10201.
24. Griesbeck, A. G.; Blunk, D.; El-Idressey, T. T.; Raabe, A. Angew. Chem., Int. Ed. 2007, 46, 8883-8886.
25. Kharasch, M. S.; Sosnovsky, G. J. Org. Chem. 1958, 23, 1322-1326, and references cited therein.
26. (a) Milas, N. A.; Golubović, A. J. Am. Chem. Soc. 1959, 81, 6461-6462.
27. (b) Milas, N. A.; Golubović, A. J. Org. Chem. 1962, 27, 4319-4323.
28. Tsuchiya, K.; Hamada, Y.; Masuyama, A.; Nojima, M.; Mc-Cullough, K. J.; Kim, H.-S.; Shibata, Y.; Wataya, Y. Tetrahedron Lett. 1999, 40, 4077-4080.
29. Ramirez, A.; Woerpel, K. A. Org. Lett. 2005, 7, 4617-4620.
30. Peroxide oligomers are potentially hazardous and explosive: Zabicky, J. The Chemistry of Peroxides; Rappoport, Z., Ed.; Wiley: Chichester, UK, 2006; Vol. 2, Chapter 7, pp 597-774. No difficulties were encountered in the handling or purification of these compounds on small scale. Details are provided in the Supporting Information.
31. Treatment of carbonyl compounds with acidic hydrogen peroxide or its derivatives can yield peroxide oligomers and Baeyer-Villiger oxidation products: Renz, M.; Meunier, B. Eur. J. Org. Chem. 1999, 737-750.
32. Krow, G. R. Org. React. 1993, 43, 251-798.
33. (a) Ruzicka, L.; Stoll, M. Helv. Chim. Acta 1928,11, 1159-1173.
34. (b) Robinson, R.; Smith, L. H. J. Chem. Soc. 1937, 371-374.
35. Mayr, H.; Kempf, B.; Ofial, A. R. Acc. Chem. Res. 2003, 36, 66-77.
36. Details are provided in the Supporting Information.
37. Ẑmitek, K.; Zupan, M.; Iskra, J. Org. Biomol. Chem. 2007,5, 3895-3908, and references therein.
38. (a) Emmons, W. D.; Ferris, A. F. J. Am. Chem. Soc. 1953, 75, 4623-4624.
39. (b) Emmons, W. D.; Pagano, A. S. J. Am. Chem. Soc. 1955, 77, 89-92.
40. Cyclization of the 1,2-dibromo alkane in a related system has been reported: (a) Holum, J. R.; Jorenby, D.; Mattison, P. J. Org. Chem. 1964, 29, 769-776.
41. (b) Wasserman, H. H.; Barber, E. H. J. Am. Chem. Soc. 1969, 91, 3674-3675.
42. (c) Vanderwel, D.; Oehlschlager, A. C. J. Am. Chem. Soc. 1992, 114, 5081-5086.
43. (a) Gaoni, Y. J. Chem. Soc. C 1968, 2925-2934.
44. (b) Ishibashi, H.; Uehara, C.; Komatsu, H.; Ikeda, M. Chem. Pharm. Bull. 1987, 35, 2750-2754.
45. (c) Brimble, M. A.; Rowan, D. D.; Spicer, J. A. Synthesis 1995, 1263-1266.
46. Das, B.; Krishnaiah, M.; Veeranjaneyulu, B.; Ravikanth, B. Tetrahedron Lett. 2007, 48, 6286-6289.
47. Reaction conditions have not been optimized.
48. Ceruti, M.; Balliano, G.; Viola, F.; Grosa, G.; Rocco, F.; Cattel, L. J. Med. Chem. 1992, 35, 3050-3058.
49. In other experiments, 1,2-disubstituted alkenes without the phenyl group did not form the desired 1,2,4-trioxanes. It appears that the additional stability of the proposed carbocationic intermediate 33 (Table 3) conferred by the phenyl substituent allowed the product to form from a disubstituted alkene.
50. Loss of stereochemistry was also observed in trisubstituted alkene substrates (Table 2, entry 6).